Login / Signup

Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease.

Jerome AvouacAnne CauvetAlexia SteelandtYuichiro ShiraiMuriel ElhaiMasataka KuwanaOliver DistlerYannick Allanore
Published in: PloS one (2020)
These results show that KL-6 is a relevant circulating marker for the diagnosis and might be an interesting marker for the progression of RA-ILD.
Keyphrases
  • interstitial lung disease
  • rheumatoid arthritis patients
  • rheumatoid arthritis
  • disease activity
  • systemic sclerosis
  • idiopathic pulmonary fibrosis
  • ankylosing spondylitis
  • systemic lupus erythematosus